109 related articles for article (PubMed ID: 21172434)
21. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
[TBL] [Abstract][Full Text] [Related]
22. A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.
Guivarc'h PH; Vachon MG; Fordyce D
Clin Ther; 2004 Sep; 26(9):1456-69. PubMed ID: 15531008
[TBL] [Abstract][Full Text] [Related]
23. Lovastatin extended release: a review of its use in the management of hypercholesterolaemia.
Curran MP; Goa KL
Drugs; 2003; 63(7):685-99. PubMed ID: 12656649
[TBL] [Abstract][Full Text] [Related]
24. Comparing pharmacokinetic and pharmacodynamic profiles in female rats orally exposed to lovastatin by gavage versus diet.
Martín-Jiménez T; Lindeblad M; Kapetanovic IM; Chen Y; Lyubimov A
Chem Biol Interact; 2008 Jan; 171(2):142-51. PubMed ID: 17854789
[TBL] [Abstract][Full Text] [Related]
25. Effects of bile salts on the lovastatin pharmacokinetics following oral administration to rats.
Kim K; Yoon I; Chun I; Lee N; Kim T; Gwak HS
Drug Deliv; 2011 Jan; 18(1):79-83. PubMed ID: 20809680
[TBL] [Abstract][Full Text] [Related]
26. Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology.
Kumar P; Singh S; Mishra B
Acta Pharm; 2009 Mar; 59(1):15-30. PubMed ID: 19304555
[TBL] [Abstract][Full Text] [Related]
27. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects.
Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T
Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the bioavailability of 250 and 500 mg divalproex sodium extended-release tablets in healthy volunteers.
Dutta S; Zhang Y; Lee LL; O'Dea R
Biopharm Drug Dispos; 2004 Nov; 25(8):353-7. PubMed ID: 15378556
[TBL] [Abstract][Full Text] [Related]
29. Effect of the melt granulation technique on the dissolution characteristics of griseofulvin.
Yang D; Kulkarni R; Behme RJ; Kotiyan PN
Int J Pharm; 2007 Feb; 329(1-2):72-80. PubMed ID: 17027207
[TBL] [Abstract][Full Text] [Related]
30. Bioavailability of divalproex extended-release formulation relative to the divalproex delayed-release formulation.
Dutta S; Zhang Y
Biopharm Drug Dispos; 2004 Nov; 25(8):345-52. PubMed ID: 15378557
[TBL] [Abstract][Full Text] [Related]
31. The interaction of diltiazem with lovastatin and pravastatin.
Azie NE; Brater DC; Becker PA; Jones DR; Hall SD
Clin Pharmacol Ther; 1998 Oct; 64(4):369-77. PubMed ID: 9797793
[TBL] [Abstract][Full Text] [Related]
32. Optimization of melt pelletization in a high shear mixer.
Bukovec P; Kroselj V; Turk S; Vrecer F
Int J Pharm; 2009 Nov; 381(2):192-8. PubMed ID: 19580855
[TBL] [Abstract][Full Text] [Related]
33. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
34. Melt granulation of pharmaceutical powders: a comparison of high-shear mixer and fluidised bed processes.
Passerini N; Calogerà G; Albertini B; Rodriguez L
Int J Pharm; 2010 May; 391(1-2):177-86. PubMed ID: 20214959
[TBL] [Abstract][Full Text] [Related]
35. Melt granulation using a twin-screw extruder: a case study.
Van Melkebeke B; Vermeulen B; Vervaet C; Remon JP
Int J Pharm; 2006 Dec; 326(1-2):89-93. PubMed ID: 16949222
[TBL] [Abstract][Full Text] [Related]
36. In vivo evaluation of a new sustained-release formulation of morphine.
Araico A; Saadeddin A; Torres-Molina F; Peris JE
Pharmazie; 2009 Oct; 64(10):653-5. PubMed ID: 19947167
[TBL] [Abstract][Full Text] [Related]
37. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
[TBL] [Abstract][Full Text] [Related]
38. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
Chen CC; Tsai TH; Huang ZR; Fang JY
Eur J Pharm Biopharm; 2010 Mar; 74(3):474-82. PubMed ID: 20060469
[TBL] [Abstract][Full Text] [Related]
39. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
Henney HR; Shah J
Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
[TBL] [Abstract][Full Text] [Related]
40. Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
Rogers JD; Zhao J; Liu L; Amin RD; Gagliano KD; Porras AG; Blum RA; Wilson MF; Stepanavage M; Vega JM
Clin Pharmacol Ther; 1999 Oct; 66(4):358-66. PubMed ID: 10546919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
